Tirzepatide 30mg
Research Peptide
Tirzepatide is a dual GIP/GLP-1 receptor agonist used in metabolic research. Each vial contains 30mg of lyophilized peptide, ≥99% purity HPLC tested. For laboratory research use only — not for human consumption.
For research use only. Not for human consumption.
Third-party lab verification
Every batch is tested by an independent laboratory using RP-HPLC to confirm identity, purity, and endotoxin levels. Sample results for Tirzepatide 30mg shown below — lot-specific COAs available on request.
Independent Analytical Laboratory
Certificate of Analysis
Document
COA-TZP-2026-0511
Product
Tirzepatide
CAS No.
2023788-19-2
Molecular Formula
C225H348F2N48O68
Molecular Weight
4813.53 g/mol
Lot Number
TZP-2026-0511
Appearance
White lyophilized powder
Manufacture Date
2026-05-11
Retest Date
2028-05-11
Amino Acid Sequence
Y-Aib-EGTFTSDYSIY-Aib-DKAAQDFIEWLLAGGPSSGAPPPS-NH2
Test Results
| Test | Specification | Result | Status |
|---|---|---|---|
| Identification | Conforms (MS) | Conforms | Pass |
| Purity (HPLC) | ≥ 98.0% | 99.38% | Pass |
| Water Content | ≤ 5.0% | 2.4% (Karl Fischer) | Pass |
| Endotoxin | < 10 EU/mg | <5 EU/mg (LAL) | Pass |
| Single Impurity | ≤ 1.0% | 0.50% | Pass |
Method
RP-HPLC, C18, 220 nm, 0.1% TFA / ACN gradient
R. Halverson
QC Analyst
Sample document — request your lot's COA for verification.
RP-HPLC Chromatogram
Tirzepatide
Detector
UV 220 nm
Retention
11.87 min
Area %
99.38%
Plates (N)
8,218
| Peak | RT (min) | Area % | Assignment |
|---|---|---|---|
| 1 | 10.45 | 0.25 | Impurity A |
| 2 | 11.87 | 99.38 | Tirzepatide |
| 3 | 13.05 | 0.22 | Impurity B |
Sample chromatogram — lot-specific traces on request.
Illustrative sample — request your lot's COA via 907-252-1640